Li-Shiun Chen is a Psychiatry physician affiliated with Barnes-Jewish Hospital. OpenAlex indexes 32 publications with 1,628 citations (h-index 20); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Barnes Jewish Hospital Plz
Dept Psychiatry
Saint Louis, MO 631101003
Telephone
314-286-1700Registry record last updated 15 Apr 2025.
Clinical trials
1 registered study on ClinicalTrials.gov matched to this name. Itemized trial rows, roles and sponsors are part of the full profile. Why? →
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
98.3%SSRI25.9%Sertraline Hcl36%Trazodone Hcl24%Citalopram Hbr17%Fluoxetine Hcl16%Escitalopram Oxalate7%Part D<11 patientsAtypical Antipsychotic20.8%Lurasidone Hcl33%Paliperidone Er27%Quetiapine Fumarate24%Abilify Maintena9%Clozapine8%Part D<11 patients+ 9 more classes in this area
Cardiovascular
1.7%alpha-Adrenergic Blocker1.7%Prazosin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2011–2026 per NIH RePORTER. The latest:
- A multilevel intervention to personalize and improve tobacco treatment in primary care
Washington University
FY2026$657,812R01DA056050 - Precision prevention strategy to increase uptake and engagement in lung cancer screening and smoking cessation treatment
Washington University
FY2026$644,722R01CA268030 - Implementation science to scale and sustain tobacco treatment leveraging point of care paradigm and health information technology
Washington University
FY2025$1,594,797UG3CA305777
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Attitudes regarding polygenic risk testing for lung cancer: a mixed-methods study
Annals of Behavioral Medicine
2025 - Enabling tobacco treatment for gastroenterology patients via a novel low-burden point-of-care model
BMC Health Services Research
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Farrokh Dehdashti, MD
Barnes-Jewish Hospital
Sidharth Puram, MD
Barnes-Jewish Hospital
Tsuyoshi Kaneko, MD
Barnes-Jewish Hospital
Saiama Waqar, MD
Barnes-Jewish Hospital
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Jeffrey Lieberman, MD
Columbia University College of Physicians and Surgeons
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”